Article covers a study published in the BMJ and co-authored by ISMP senior scientist that calculated a median pivotal clinical trial cost for new drugs in development, and offers a breakdown of possible factors leading to those costs.
For the full text, visit Endpoints News online.
More News
Majority of Survey Respondents Agree Tall Man Lettering Helps Prevent Errors
ECRI’s report warns of potential safety risks with 10 health technologies, including single-use products, medication cabinets, cybersecurity of cloud-based systems, and ventilator disinfection
I knew if I wanted to become a subject matter expert and advance through the ranks of medication safety specialists, I needed to align myself with the organization considered the gold standard for medication safety information.